白内障手术结束时前房内注射头孢呋辛、莫西沙星与万古霉素的安全性和有效性对比分析:一项Meta分析
该Meta分析纳入17项研究、超过90万只眼,比较白内障超声乳化手术结束时前房内注射头孢呋辛、莫西沙星或万古霉素预防术后眼内炎的效果与安全性。结果显示前房内抗生素总体有利于降低眼内炎风险(OR 0.20;95%CI 0.13至0.32;P<0.00001),三种药物平均加权眼内炎发生率分别为0.0332%、0.0153%和0.0106%。作者结论认为头孢呋辛和莫西沙星在标准剂量下可降低眼内炎发生率且毒性事件极少或无,前房内抗生素单用可能与前房内联合局部抗生素同样有效。
要点
- 17项研究、超过90万只眼支持白内障手术结束时使用前房内抗生素(OR 0.20;95%CI 0.13至0.32;P<0.00001)。
- 头孢呋辛、莫西沙星、万古霉素平均加权眼内炎发生率分别为0.0332%、0.0153%、0.0106%。
- 前房内联合局部抗生素与前房内单用抗生素在有效性上无差异(P>0.3)。
核心结论
- 作者结论认为,头孢呋辛和莫西沙星在标准剂量下与对照组相比降低了眼内炎发生率,且毒性事件极少或无。
- 作者结论认为,前房内抗生素单用可能与前房内联合局部抗生素同样有效。
研究设计与样本
- 系统综述与Meta分析,遵循流行病学观察性研究Meta分析(Meta-analysis of Observational Studies in Epidemiology)指南,比较前房内头孢呋辛、莫西沙星和万古霉素预防超声乳化白内障手术眼内炎的有效性,并同期进行前房内抗生素安全性分析。
- 检索BIOSIS Previews、CINAHL、ClinicalTrials.gov、Cochrane Library、Dissertations & Theses、EMBASE、PubMed、ScienceDirect和Scopus,检索时间自建库至2017年1月。
- 采用随机效应模型合并数据,由两名独立评价者分别审阅文章并提取数据,并进行了漏斗图、偏倚风险和质量证据分析。
- 共纳入17项研究、超过90万只眼。
主要发现
- 前房内抗生素有利于降低白内障手术结束时眼内炎风险(OR 0.20;95%CI 0.13至0.32;P<0.00001)。
- 前房内头孢呋辛、莫西沙星和万古霉素的平均加权术后眼内炎发生率分别为0.0332%、0.0153%和0.0106%。
- 二次分析显示,前房内联合局部抗生素与前房内单用抗生素在有效性上无差异(P>0.3)。
- 多数研究偏倚风险为低至中等。
- 安全性分析显示莫西沙星毒性极小,头孢呋辛的毒性多数由给药错误导致,万古霉素虽罕见但与视网膜毒性事件相关。
关键数值与推荐
- 前房内抗生素对比对照的眼内炎OR 0.20(95%CI 0.13至0.32;P<0.00001)。
- 前房内头孢呋辛平均加权术后眼内炎发生率为0.0332%。
- 前房内莫西沙星平均加权术后眼内炎发生率为0.0153%。
- 前房内万古霉素平均加权术后眼内炎发生率为0.0106%。
- 前房内联合局部抗生素与前房内单用抗生素有效性比较P>0.3。
临床怎么用
- 作者结论认为头孢呋辛和莫西沙星在标准剂量下与对照组相比降低了眼内炎发生率,且毒性事件极少或无。
- 作者结论认为前房内抗生素单用可能与前房内联合局部抗生素同样有效。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current practice methods are unclear as to the most safe and effective prophylactic pharmacotherapy and method of delivery to reduce postoperative endophthalmitis occurrence. METHODS: A systematic review and meta-analysis using Meta-analysis of Observational Studies in Epidemiology guidelines was performed to compare the efficacy of intracameral cefuroxime, moxifloxacin and vancomycin in preventing postphacoemulsification cataract surgery endophthalmitis. A safety analysis of intracameral antibiotics was concurrently performed. DATA SOURCES: BIOSIS Previews, CINAHL, ClinicalTrials.gov, Cochrane Library, Dissertations & Theses, EMBASE, PubMed, ScienceDirect and Scopus were searched from inception to January 2017. Data were pooled using a random effects model. All articles were individually reviewed and data were extracted by two independent reviewers. Funnel plot, risk of bias and quality of evidence analyses were performed. RESULTS: Seventeen studies with over 900 000 eyes were included, which favoured the use of intracameral antibiotics at the end of cataract surgery (OR 0.20; 95% CI 0.13 to 0.32; P<0.00001). The average weighted postoperative endophthalmitis incidence rates with intracameral cefuroxime, moxifloxacin and vancomycin were 0.0332%, 0.0153% and 0.0106%, respectively. Secondary analyses showed no difference in efficacy between intracameral plus topical antibiotics versus intracameral alone (P>0.3). Most studies had low to moderate risk of bias. The safety analysis showed minimal toxicity for moxifloxacin. Dosing errors led to the majority of toxicities with cefuroxime. Although rare, vancomycin was associated with toxic retinal events. CONCLUSION: Intracameral cefuroxime and moxifloxacin reduced endophthalmitis rates compared with controls with minimal or no toxicity events at standard doses. Additionally, intracameral antibiotics alone may be as effective as intracameral plus topical antibiotics.
引用
- Bowen RC, Zhou AX, Bondalapati S, et al. Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis. Br J Ophthalmol. 2018. PMID: 29326317. doi:10.1136/bjophthalmol-2017-311051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。